Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page
- Check5 days agoChange DetectedThe page shows a new Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor version update to the page’s documentation or system, with no changes to the study information.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a minor backend or formatting update without changes to study information.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.6.3 is now shown, replacing the previous v3.6.0. This appears to be a minor maintenance update to the page’s versioning rather than a substantive change to the study information.SummaryDifference0.0%

- Check62 days agoChange DetectedNew guidance and navigation sections have been added to help users read the study record and join the study. Recruitment status indicates no longer looking for participants, and the page revision was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check70 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a maintenance or feature update to the page rendering.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page, indicating a newer version of the content.SummaryDifference0.0%

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.